학술논문
Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia May 2019 19(5):275-284
Subject
Language
ISSN
2152-2650